Abstract
Social anxiety disorder (SOC) is characterized by marked and persistent fear of one or more social performance situations in which the person is exposed to unfamiliar people or to possible scrutiny. The person fears that she or he might act in a way that will be humiliating or embarrassing. Children and adolescents with this disorder often have great impairment in their academic performance, social skills, peer relationships, and family life. Early diagnosis is vital. Primary care providers are in a unique situation to first diagnose and treat SOC in children and adolescents.
There is evidence of successful pharmacologic and psychosocial treatment in pediatric SOC. Serotonin reuptake inhibitors, which are considered first-line medications for SOC, have shown promising results in open-label and double-blind trials. Studies have demonstrated that psychosocial treatments, specifically cognitive-behavioral therapy and group therapy, are efficacious in pediatric SOC. There is some evidence that the use of combination therapy, both pharmacology and psychosocial treatment, is beneficial in the management of pediatric SOC.
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press. 1994
Lipsitz JD, Schneier FR. Social phobia: epidemiology and cost of an illness. Pharmacoeconomics 2000; 18Suppl. 1: 23–32
Stemberger RT, Turner SM, Beidel DD, et al. Social phobia: an analysis of possible developmental factors. J Abnorm Psychol 1995; 104: 526–31
Turner SM, Beidel DC, Townsley RM. Social phobia: relationship to shyness. Behav Res Ther 1990; 28: 497–505
Chavira DA, Stein MB, Malcarne VL. Scrutinizing the relationship between shyness and social phobia. J Anxiety Disord 2002; 16: 585–98
Briggs-Gowan MJ, Horwitz SM, Schwab-Stone M, et al. Mental health in pediatric settings: distribution of disorders and factors related to service use. J Am Acad Child Adolesc Psychiatry 2000; 39: 841–9
Busch B, Biederman J, Cohen L, et al. Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Serv 2002; 53: 1103–11
Costello EJ. Child psychiatric disorders and their correlates: a primary care pediatric sample. J Am Acad Child Adolesc Psychiatry 1989; 28: 851–5
Chavira DA, Stein MB, Bailey K, et al. Child anxiety in primary care: prevalent but untreated. Depress Anxiety 2004; 20: 155–64
Wren FJ, Scholle SH, Heo J, et al. Pediatric mood and anxiety syndromes in primary care: who gets identified. Int J Psychiatry Med 2003; 33: 1–16
Essau CA, Conradt J, Petermann F. Frequency and comorbidity of social phobia and social fears in adolescents. Behav Res 1999; 37: 831–43
Wittchen HU, Nelson CB, Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 1998; 28: 109–26
Heimberg RG, Stein MB, Hiripi E, et al. Trends in the prevalence of social phobia in the United States: a synthetic cohort analysis of changes over four decades. Eur Psychiatry 2000; 15: 29–37
Lewinsohn PM, Hops H, Roberts RE, et al. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psych 1993; 102: 133–44
Schneier FR, Johnson J, Hornig CD, et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992; 49: 282–8
Beidel DC, Turner SM. Shy children, phobic adults: nature and treatment of social phobia. Washington, DC: American Psychological Association, 1998
Biedel DC, Turner SM, Morris TL. Behavioural treatment of childhood social phobia. J Consult Clin Pysychol 2000; 68: 1072–80
Sareen J, Stein M. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Drugs 2000; 59Suppl. 3: 497–509
Lecrubier Y. Comorbidity in social anxiety disorder: impact on disease burden and management. J Clin Psychiatry 1998; 59Suppl. 7: 33–7
Beidel DC, Turner SM, Morris TL. Psychopathology of childhood social phobia. J Am Acad Child Adolesc Psychiatry 1999; 38Suppl. 6: 643–50
La Greca AM, Stone WL. Social Anxiety Scale for Children-Revised: factor structure and concurrent validity. J Clin Child Psychol 1993; 22: 17–26
Beidel DC, Turner SM, Morris TL, et al. A new inventory to assess childhood social anxiety and phobia: the Social Phobia and Anxiety Inventory for Children. Psychol Assess 1995; 7: 73–9
March J, Parker J, Sullivan K, et al. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability and validity. J Am Acad Child Adolesc Psychiatry 1997; 36: 554–65
Birmaher B, Khetarpal S, Brent D, et al. The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry 1997; 36: 545–53
La Greca AM, Lopez N. Social anxiety among adolescents: linkages with peer relationships and friendships. J Abnorm Child Psychol 1998; 26: 83–94
La Greca AM, Dandes SK, Wick PL, et al. Development of the Social Anxiety Scale for Children: reliability and concurrent validity. J Clin Child Psychol 1988; 17: 84–91
Garcia-Lopez LJ, Olivares J, Hidalgo M, et al. Psychometric properties of the Social Phobia and Anxiety Inventory, the Social Anxiety Scale for Adolescents, the Fear of Negative Evaluation Scale, and the Social Avoidance and Distress Scale in an adolescent Spanish-speaking sample. J Psychopathol Behav Assess 2001; 23: 51–9
Ollendick TH. Reliability and validity of the Revised Fear Surgery Schedule for Children (FSSC-R). Behav Res Ther 1983; 21(6): 685–92
Beck JG, Carmin CN, Henninger NJ. The utility of the Fear Survey Schedule-III: an extended replication. J Anxiety Disord 1998; 12: 177–82
Achenbach TM. Manual for the Child Behavior Checklist/4–18 and 1991 Profile. Burlington, VT: University of Vermont, Department of Psychiatry, 1991
Reynolds CR, Richmond B. What I think and feel: a revised measure of children’s manifest anxiety. J Abnorm Child Psychol 1978; 6: 271–80
Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry 1987; 22: 141–73
Silverman WK, Albano AM. Anxiety Disorders Interview Schedule for DSM-IV, child version. San Antonio (TX): Graywind Publications Incorporated, 1996
Albano AM, Silverman WK. Anxiety Disorders Interview Schedule for DSM-IV, child version: clinician manual. Albany (NY): Graywind Publications, 1994
Silverman WK, Nelles WB. The Anxiety Disorders Interview Schedule for Children. J Am Acad Child Adolesc Psychiatry 1992; 27: 772–8
Albano AM, Knox LS, Barlow DH. Obsessive-compulsive disorder. In: Eisen AR, Kearney CA, Schaefer CE, editors. Clinical handbook of anxiety disorders in children and adolescents. Northvale (NJ): Jason Aronson, 1995: 282–316
The RUPP Anxiety Study Group. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002: 41(9): 1061–9
Zaider TI, Heimberg RG. Nonpharmacologic treatments for social anxiety disorder. Acta Psychiatr Scand 2003; 108Suppl. 417: 72–84
Beidel DC, Turner SM, Morris TL. Behavioral treatment of childhood social phobia. J Consult Clin Psychol 2000; 68: 1072–80
Flannery-Schroeder EC, Kendall P. Group and individual cognitive-behavioral treatments for youth with anxiety disorders: a randomized clinical trial. Cognit Ther Res 2000; 24: 251–78
March J, Wells K. Combining medication and psychotherapy. In: Martin A, Scahill L, Charney DS, et al., editors. Pediatric psychopharmacology: principles and practice. New York: Oxford University Press, 2003: 426–46
Barrett PM, Dadds MR, Rapee RM. Family treatment of childhood anxiety: a controlled trial. J Consult Clin Psychol 1996; 64: 333–42
Kendall PC, Flannery-Schroeder E, Panichelli-Mindel SM, et al. Therapy for youths with anxiety disorders: a second randomized clinical trial. J Consult Clin Psychol 1997 Jun; 65(3): 366–80
Hayward C, Varady S, Albano AM, et al. Cognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study. J. Am Acad Child Adolesc Psychiatry 2000 Jun; 39Suppl. 6: 721–72
Silverman WK, Kurtines WM, Ginsburg CF, et al. Treating anxiety disorders in children with group cognitive behavioral therapy: a randomized clinical trial. J Consult Clin Psychol 1999 Dec; 67Suppl. 6: 995–1003
Muris P, Mayer B, Bartelds E, et al. The revised version of the Screen for Child Anxiety Related Emotional Disorders (SCARED-R): treatment sensitivity in an early intervention trial for childhood anxiety disorders. Br J Clin Psychol 2001; 40: 323–36
Nauta MH, Scholing A, Emmelkamp PM, et al. Cognitive-behavioral therapy for children with anxiety disorders in a clinical setting: no additional effect of a cognitive parent training. J Am Acad Child Adolesc Psychiatry 2003; 42: 1270–8
Silverman WK, Kurtines WM, Ginsburg GS, et al. Contingency management, self-control, and education support in the treatment of childhood phobic disorders: a randomized clinical trial. J Consult Clinical Psychol 1999; 67: 675–87
Spence SH, Donovan C, Brechman-Toussant M. The treatment of childhood social phobia: the effectiveness of a social skills training-based, cognitive-behavioral intervention, with and without parental involvement. J Child Psychol Psychiatry 2000; 41Suppl. 6: 713–26
Barrett PM. Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders. J Clin Child Psychol 1998; 27: 459–68
Cobham VE, Dadds MR, Spence SH. The role of parental anxiety in the treatment of childhood anxiety. J Consult Clin Psychol 1998; 66: 893–905
Kendall PC. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol 1994 Feb; 62(1): 100–10
Shortt AL, Barrett PM, Fox TL. Evaluating the FRIENDS program: a cognitive-behavioral group treatment for anxious children and their parents. J Clin Child Psychol 2001; 30(4): 525–35
Dummit S, Klein RG, Tancer NK, et al. Fluoxetine treatment of children with selective mutism. J Am Acad Child Adoles Psychiatry 1996; 35Suppl. 5: 615–21
Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994; 33: 1000–6
The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001; 344: 1279–85
Compton SN, Grant PJ, Chrisman AK, et al. Sertraline in children with social anxiety disorder: an open trial. J Am Acad Child Adolesc Psychiatry 2001; 409Suppl. 5: 564–71
Wagner KD, Berard J, Stein MB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry 2004; 61: 1153–62
March JS, Entusah AR, Rynn M, et al. A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry. Epub 2007 Jun 4
Simeon JG, Ferguson HB. Alprazolam effects in children with anxiety disorders. Can J Psychiatry 1987; 32: 570–3
Simeon JG, Ferguson HB, Knott V, et al. Clinical, cognitive and neuropsychological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 1992; 31Suppl. 1: 29–33
Selak I. Pregabalin (Pfizer). Curr Opin Investig Drugs 2001 Jun; 2(6): 828–34
Stewart DE. Hepatic adverse events associated with nefazodone. Can J Psychiatry 2002; 7Suppl. 4: 375–7
Newman TB. A black-box warning for antidepressants in children? N Engl J Med 2004 Oct 14; 351(16): 1595–8
Leonard HL, March J, Rickler KC, et al. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents; J Am Acad Child Adolesc Psychiatry 1997; 36: 725–36
Labellarte MJ, Walkup JT, Riddle MA. The new antidepressants: selective serotonin reuptake inhibitors. Ped Clin North Am 1998; 45: 1137–55
Chavira DA, Stein MB. Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder. J Child Adolesc Psychopharmacology 2002; 12Suppl. 1: 47–54
Kendall PC. Child/Anxiety Multimodal Study (CAMS). Grant # MH 63747 (4 years). National Institute of Mental Health, 2002 [online]. Available from URL: http://clinicaltrials.gov (identifier NCT00052078) [Accessed 2007 Jul 25]
Acknowledgements
No sources of funding were used to assist in the preparation of this review. Dr Moira Rynn has served as a consultant to and received research grants from Wyeth, Pfizer, and Eli Lilly.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khalid-Khan, S., Santibanez, MP., McMicken, C. et al. Social Anxiety Disorder in Children and Adolescents. Pediatr-Drugs 9, 227–237 (2007). https://doi.org/10.2165/00148581-200709040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00148581-200709040-00004